Dr Dong Wei, CEO of EdiGene, shares the fascinating story behind the establishment of EdiGene, including his close relationship with EdiGene founder Professor Wensheng Wei; the insights he bring from his extensive and varied industry career from biotechs to Big Pharma; and the mission of EdiGene to translate the potential of current gene-editing technologies into novel platforms and therapeutics that truly serve the needs of patients globally.
For patients suffering from genetic diseases in China, the frequent and chronic healthcare models that we see in the US and EU may not work
